Ra Medical Systems reports Q1 loss of $5.5M, CFO Andrew Jackson resigns

Catheter Precision, Inc.

Revenue of $9,000 in Q1 2022, up from $4,000 in Q1 2021; minimal product sales.
Loss from continuing operations $5.5M ($0.27 per share) vs $6.9M ($2.36) a year ago.
CFO Andrew Jackson to resign effective May 25, 2022; resignation not due to any disagreement.
Enrolled 107 of 125 subjects in pivotal atherectomy trial; filed 510(k) for next-gen DABRA 2.0 catheter.
Completed public offering for ~$9.7M net proceeds; engaged investment bank to review strategic alternatives.

item 2.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Andrew Jackson

Chief Financial Officer and Secretary

VTAK · Catheter Precision, Inc.

Effective: 2022-05-25
Filed: May 16, 2022, 7:59 PM ET

On May 10, 2022, Andrew Jackson notified Ra Medical Systems, Inc. (the “Company”) that he will resign as the Company’s Chief Financial Officer and Secretary, effective May 25, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Andrew Jackson departed as Chief Financial Officer and Secretary at Catheter Precision, Inc..

Action: resign
Role: Chief Financial Officer and Secretary

Exact text from the filing

On May 10, 2022, Andrew Jackson notified Ra Medical Systems, Inc. (the “Company”) that he will resign as the Company’s Chief Financial Officer and Secretary, effective May 25, 2022.

View on SEC.gov

Catheter Precision, Inc. filing history →

Source: SEC EDGAR

accession 0001564590-22-020412

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.